In New York state, IFF and Kemira announced the formation of Alpha Bio, a joint venture aimed at commercial-scale production of renewable biobased materials. With an investment of approximately €130 million, the Alpha Bio facility will start production in late 2027, converting up to 44,000 MT of plant sugars to bioproducts, including high-performance biopolymers for […]
In New York, specialty chemical companies IFF and Kemira have formed a joint venture to produce biobased materials at commercial scale production. Dubbed Alpha Bio, the €130 million (US$140 million) will begin converting up to 44,000 MT of plant sugars to bioproducts in late 2027. Targeted products include high-performance biopolymers for use in various applications, […]
In Finland, Kemira and IFF have completed construction of a “market-entry scale” industrial biobased polymer plant. The unit is capable of producing unique renewable polymers for Kemira’s customers and is based on the patented Designed Enzymatic Biomaterial platform technology developed by IFF. The unit will be operated by Chemigate, a member of the Berner Group, […]
